Evidence map›Paper›PMID 24599728›Full record

ArticleBiopolymers2014

Adapter reagents for protein site specific dye labeling.

Darren A Thompson, Eric G B Evans, Tomas Kasza, Glenn L Millhauser, Philip E Dawson

Open access · bronzeAbstract read
In one paragraph

Article in Biopolymers, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Darren A ThompsonDepartment of Chemistry, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA, 92037.
Eric G B Evans
Tomas Kasza
Glenn L Millhauser
Philip E Dawson
University of California, Santa Cruz · USScripps Research Institute · US

Funding

Molecular Aspects of Copper Binding to the Prion ProteinR01GM065790 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI MILLHAUSER, GLENN L · 2002 to 2018
$4.5M
Synthetic Protein ChemistryR01GM098871 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI DAWSON, PHILIP E · 2011 to 2014
$1.4M
NIGMS NIH HHS GM065790NIGMS NIH HHS GM098871NIGMS NIH HHS R01 GM065790NIGMS NIH HHS R01 GM098871
6 · The paper itself

Abstract

Chemoselective protein labeling remains a significant challenge in chemical biology. Although many selective labeling chemistries have been reported, the practicalities of matching the reaction with appropriately functionalized proteins and labeling reagents is often a challenge. For example, we encountered the challenge of site specifically labeling the cellular form of the murine Prion protein with a fluorescent dye. To facilitate this labeling, a protein was expressed with site specific p-acetylphenylalanine. However, the utility of this acetophenone reactive group is hampered by the severe lack of commercially available aminooxy fluorophores. Here we outline a general strategy for the efficient solid phase synthesis of adapter reagents capable of converting maleimido-labels into aminooxy or azide functional groups that can be further tuned for desired length or solubility properties. The utility of the adapter strategy is demonstrated in the context of fluorescent labeling of the murine Prion protein through an adapted aminooxy-Alexa dye.

Indexed as

Staining and LabelingAmino Acid SequenceAnimalsChromatography, High Pressure LiquidChromatography, Reverse-PhaseColoring AgentsElectrophoresis, Polyacrylamide GelIndicators and ReagentsMiceMolecular Sequence DataPeptidesPrionsColoring AgentsIndicators and ReagentsPeptidesPrionsbioconjugationchemoselectiveketoxime

Identifiers

PMID24599728
PMCPMC4851436
OpenAlexW2162848788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.